# Honeywell International Inc: Form 10-K for the period ended Dec 31, 2024

- Company: [Honeywell International Inc](/companies/hon.md) (CIK 773840)
- Form: 10-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 14:50 ET
- Period: 2024-12-31
- Accession: 0000773840-25-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/773840/000077384025000010/hon-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/773840/000077384025000010/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $38.50bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $23.84bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $1.54bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2024-01-01 to 2024-12-31 | $5.47bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | $8.70bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $1.47bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | $5.71bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $8.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $8.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 655,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | $6.10bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $1.16bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2024-01-01 to 2024-12-31 | $2.90bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2024-01-01 to 2024-12-31 | $1.66bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2024-12-31 | $10.57bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $27.91bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $75.20bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $21.26bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2024-12-31 | $27.27bn | us-gaap:LongTermDebt |
| Short-term borrowings | at 2024-12-31 | $4.27bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $18.62bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/773840/000077384025000010/hon-20241231.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000773840-25-000010. Last ingested by Listed: Nov 2, 2026, 18:46 ET. No prices; not investment advice.